Annette H M van der Helm-van Mil Selected Research

Osteitis

1/2023	The Natural Sequence in Which Subclinical Inflamed Joint Tissues Subside or Progress to Rheumatoid Arthritis: A Study of Serial MRIs in the TREAT EARLIER Trial.
12/2022	ACPA-negative and ACPA-positive RA patients achieving disease resolution demonstrate distinct patterns of MRI-detected joint-inflammation.
10/2022	Intermetatarsal Bursitis, a Novel Feature of Juxtaarticular Inflammation in Early Rheumatoid Arthritis Related to Clinical Signs: Results of a Longitudinal Magnetic Resonance Imaging Study.
1/2016	MRI-detected osteitis is not associated with the presence or level of ACPA alone, but with the combined presence of ACPA and RF.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Annette H M van der Helm-van Mil Research Topics

Disease

66	Rheumatoid Arthritis 02/2024 - 01/2005
41	Arthritis (Polyarthritis) 02/2024 - 10/2005
23	Inflammation (Inflammations) 11/2023 - 01/2013
14	Arthralgia (Joint Pain) 04/2024 - 09/2013
11	Synovitis 12/2022 - 05/2015
5	Fatigue 04/2024 - 01/2015
4	Osteitis 01/2023 - 01/2016
4	Tenosynovitis 10/2022 - 05/2015
3	Autoimmune Diseases (Autoimmune Disease) 11/2020 - 10/2011
3	Disease Progression 08/2017 - 01/2005
2	Reactive Arthritis (Reiter Disease) 11/2015 - 01/2010
2	Bone Resorption 05/2014 - 05/2013
2	Infections 07/2010 - 01/2010
1	Periodontal Diseases (Periodontal Disease) 04/2024
1	Back Pain (Backache) 02/2024
1	Genetic Risk Score 01/2023
1	COVID-19 01/2022
1	Sarcoidosis (Schaumann Disease) 01/2021
1	Systemic Scleroderma (Systemic Sclerosis) 07/2018
1	Chronic Disease (Chronic Diseases) 08/2017
1	Leprosy (Hansen's Disease) 08/2017
1	Myalgia 05/2016
1	Edema (Dropsy) 01/2016
1	Psoriatic Arthritis 11/2015
1	Experimental Arthritis 05/2013
1	Dyslipidemias (Dyslipidemia) 01/2013
1	Disease Susceptibility (Diathesis) 01/2013
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2013
1	Neoplasms (Cancer) 01/2010
1	Sepsis (Septicemia) 01/2010

Drug/Important Bio-Agent (IBA)

26	AutoantibodiesIBA 02/2024 - 05/2005
21	Anti-Citrullinated Protein AntibodiesIBA 01/2024 - 01/2005
21	Antirheumatic Agents (DMARD)IBA 12/2022 - 08/2008
21	AntibodiesIBA 11/2020 - 01/2005
16	Proteins (Proteins, Gene)FDA Link 11/2020 - 01/2005
10	EpitopesIBA 01/2023 - 05/2005
7	C-Reactive ProteinIBA 02/2024 - 09/2013
7	Methotrexate (Mexate)FDA LinkGeneric 01/2023 - 02/2007
7	Peptides (Polypeptides)IBA 10/2016 - 09/2013
6	amsonic acid (DAS)IBA 02/2024 - 06/2012
6	Rheumatoid FactorIBA 11/2018 - 08/2009
5	acetyl 4-aminosalicylic acidIBA 01/2022 - 08/2009
5	HLA-DRB1 Chains (HLA DRB1)IBA 01/2015 - 10/2005
4	cyclic citrullinated peptideIBA 08/2009 - 01/2005
3	ametantrone (HAQ)IBA 04/2024 - 12/2016
3	Acute-Phase Proteins (Acute-Phase Protein)IBA 11/2023 - 09/2013
3	GadoliniumIBA 06/2023 - 10/2014
3	Biomarkers (Surrogate Marker)IBA 10/2018 - 02/2016
3	AntigensIBA 02/2012 - 08/2011
2	CytokinesIBA 06/2023 - 11/2020
2	ChemokinesIBA 06/2023 - 11/2020
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022 - 05/2005
2	Immunoglobulin G (IgG)IBA 01/2022 - 01/2017
2	OsteoprotegerinIBA 05/2016 - 05/2014
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2014 - 07/2010
2	TNF Receptor-Associated Factor 1IBA 01/2010 - 09/2007
1	Abatacept (Orencia)FDA Link 02/2024
1	Prostaglandins AIBA 08/2023
1	insulin receptor-related receptor (IRR)IBA 12/2022
1	IMB 10IBA 10/2022
1	TabletsIBA 01/2022
1	Contrast MediaIBA 01/2022
1	GlucocorticoidsIBA 01/2022
1	CC ChemokinesIBA 01/2021
1	Insulin-Like Growth Factor I (IGF-1)IBA 11/2020
1	Anti-Idiotypic AntibodiesIBA 12/2017
1	Interferon-gamma (Interferon, gamma)IBA 08/2017
1	IgG Receptors (Fc gamma RI)IBA 02/2016
1	ORALIT (ORS)IBA 01/2016
1	CitrullineIBA 10/2015
1	AllergensIBA 10/2015
1	AcidsIBA 01/2015
1	Amino Acids FDA Link 01/2015
1	TNF Receptor-Associated Factor 6 (TRAF6)IBA 05/2014
1	LigandsIBA 05/2014
1	pyridinolineIBA 08/2013
1	CollagenIBA 08/2013
1	Peptide Hydrolases (Proteases)FDA Link 05/2013
1	Pattern Recognition ReceptorsIBA 05/2013
1	Cathepsin KIBA 05/2013
1	LipidsIBA 01/2013
1	ApolipoproteinsIBA 01/2013
1	Apolipoproteins E (ApoE)IBA 01/2013
1	SalicylatesIBA 07/2010
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2010
1	Azithromycin (Zithromax)FDA LinkGeneric 01/2010
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2010
1	VimentinIBA 08/2009
1	HLA-DR Antigens (HLA-DR)IBA 12/2007
1	HLA-DR3 Antigen (HLA DR3 Antigen)IBA 10/2005
1	Transcription Factors (Transcription Factor)IBA 05/2005

Therapy/Procedure

10	Therapeutics 12/2022 - 08/2009
2	Aftercare (After-Treatment) 01/2023 - 11/2022
1	Tooth Extraction (Tooth Extractions) 04/2024
1	Oral Administration 01/2022